At a glance
- Originator Peptor; Yissum Research Development Company
- Class Cyclic peptides
- Mechanism of Action Somatostatin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pancreatitis
Most Recent Events
- 28 Sep 2002 Discontinued - Preclinical for Pancreatitis in Israel (unspecified route)
- 28 Sep 2001 No-Development-Reported for Pancreatitis in Israel (Unknown route)
- 17 Sep 1998 New profile